CINECA IRIS Institutional Research Information System

VITTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 41.577
EU - Europa 23.809
AS - Asia 16.953
SA - Sud America 2.381
Continente sconosciuto - Info sul continente non disponibili 850
AF - Africa 799
OC - Oceania 53
Totale 86.422
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.138
IT - Italia 10.961
SG - Singapore 5.079
CN - Cina 4.831
CA - Canada 3.155
HK - Hong Kong 2.737
SE - Svezia 2.499
FI - Finlandia 2.393
DE - Germania 2.280
BR - Brasile 1.939
VN - Vietnam 1.471
BG - Bulgaria 1.176
GB - Regno Unito 945
TR - Turchia 837
FR - Francia 796
RU - Federazione Russa 543
NL - Olanda 511
UA - Ucraina 468
AT - Austria 422
IN - India 409
KR - Corea 314
CI - Costa d'Avorio 287
JP - Giappone 268
BD - Bangladesh 183
CH - Svizzera 166
SN - Senegal 147
AR - Argentina 132
MX - Messico 124
PK - Pakistan 114
PL - Polonia 107
IQ - Iraq 105
BE - Belgio 97
ZA - Sudafrica 94
ES - Italia 85
ID - Indonesia 82
SA - Arabia Saudita 72
EC - Ecuador 71
IE - Irlanda 69
UZ - Uzbekistan 56
VE - Venezuela 55
MY - Malesia 54
GR - Grecia 53
NG - Nigeria 46
CO - Colombia 45
AU - Australia 43
MA - Marocco 43
PY - Paraguay 43
RO - Romania 38
PH - Filippine 34
KE - Kenya 33
CL - Cile 32
UY - Uruguay 31
CR - Costa Rica 30
IR - Iran 30
EG - Egitto 29
IL - Israele 27
JO - Giordania 26
LT - Lituania 26
LV - Lettonia 25
DZ - Algeria 24
CZ - Repubblica Ceca 23
NP - Nepal 21
PE - Perù 21
KZ - Kazakistan 20
TT - Trinidad e Tobago 20
AL - Albania 19
JM - Giamaica 19
OM - Oman 19
TN - Tunisia 19
AE - Emirati Arabi Uniti 18
TH - Thailandia 18
AZ - Azerbaigian 17
BJ - Benin 15
HU - Ungheria 15
PA - Panama 15
PS - Palestinian Territory 15
TW - Taiwan 15
EE - Estonia 14
ET - Etiopia 13
GT - Guatemala 13
ZM - Zambia 13
DK - Danimarca 11
EU - Europa 11
LB - Libano 10
LY - Libia 10
NZ - Nuova Zelanda 10
BB - Barbados 9
KG - Kirghizistan 9
NO - Norvegia 9
RS - Serbia 9
SY - Repubblica araba siriana 9
BH - Bahrain 8
BO - Bolivia 8
DO - Repubblica Dominicana 8
GE - Georgia 8
HN - Honduras 8
HR - Croazia 8
PT - Portogallo 8
SV - El Salvador 8
SM - San Marino 7
Totale 85.460
Salva come PNG Salva come JPEG
Città #
Ashburn 4.127
Woodbridge 3.406
Fairfield 3.264
Singapore 2.860
Hong Kong 2.682
Ann Arbor 2.471
Houston 2.432
Montreal 2.363
Chandler 2.144
Helsinki 1.968
San Jose 1.705
Santa Clara 1.665
Dallas 1.649
Milan 1.505
Seattle 1.365
Wilmington 1.202
Sofia 1.169
Cambridge 1.059
Beijing 1.028
Shanghai 1.001
New York 832
Ottawa 634
Rome 589
Boardman 510
Princeton 509
Serra 477
Los Angeles 475
Jacksonville 455
Izmir 448
Lawrence 447
Hefei 409
Medford 399
Lauterbourg 395
Ho Chi Minh City 370
Vienna 370
Florence 359
Nanjing 339
Des Moines 331
Council Bluffs 296
Seoul 292
Abidjan 286
Hanoi 268
Munich 262
Istanbul 243
Tokyo 220
Dearborn 202
Frankfurt am Main 202
Buffalo 185
Pisa 184
Naples 180
São Paulo 171
Dong Ket 169
London 166
Redondo Beach 162
Boulder 155
San Diego 155
Dakar 147
Columbus 143
The Dalles 139
Bologna 127
Redwood City 122
Falls Church 119
Nanchang 118
Bern 116
Bremen 114
Bari 112
Palermo 104
Jüchen 100
Menlo Park 98
Lancaster 95
Ogden 93
Turin 89
Atlanta 86
Brussels 85
Kunming 82
Shenyang 81
Orem 76
Guangzhou 75
Marseille 75
Hebei 74
Catania 73
Düsseldorf 72
Fuzhou 71
Chicago 70
Changsha 66
Tianjin 66
Brescia 65
Turku 65
Phoenix 64
Washington 64
Rio de Janeiro 60
Detroit 58
San Francisco 57
Brooklyn 56
Jiaxing 56
Amsterdam 53
Genoa 53
Lahore 51
Tashkent 51
Jinan 50
Totale 56.902
Salva come PNG Salva come JPEG
Nome #
Tiroidite cronica autoimmune 12.811
Natural history of graves’ orbitopathy after treatment 452
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 390
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 377
Ontogenetic development of pancreatic thyrotropin-releasing hormone in human foetuses and in infants. 357
The role of nuclear medicine in the clinical management of benign thyroid disorders. Part 1. Hyperthyroidism 342
Gozzo diffuso tossico (morbo di Flajani-Basedow-Graves) e tiroidite cronica autoimmune, Inquadramento nosologico e terapia medica 301
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 293
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 277
Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndrome 271
Serum Insulin-Like Growth Factor-1 Concentrations Are Reduced in Severely Obese Women and Raise After Weight Loss Induced by Laparoscopic Adjustable Gastric Banding 268
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 257
Leonardo da Vinci "Design of Lady with Graves' disease" (1452-1519) 256
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 254
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 254
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 253
Artificial neural networks in the outcome prediction of adjustable gastric banding in obese women. 253
Thyroid ultrasonography reporting: consensus of Italian Thyroid Association (AIT), Italian Society of Endocrinology (SIE), Italian Society of Ultrasonography in Medicine and Biology (SIUMB) and Ultrasound Chapter of Italian Society of Medical Radiology (SIRM) 251
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 249
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 247
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 246
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 246
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 242
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 242
Sera of patients with idiopathic myxedema contain IgG which block TSH-stimulated thyroid adenylate cyclase 238
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 238
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer 238
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 234
Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding 233
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 233
Proteomic analysis of fine-needle aspiration in differential diagnosis of thyroid nodules. 232
Thyroid autoimmunity, thyroglobulin autoantibodies and thyroid cancer prognosis 230
Effects Of Long-term Tamoxifen Therapy On The Course Of Chronic Autoimmune Thyroiditis 228
Expression of the microsomal antigen on the surface of continuously cultured rat thyroid cells is modulated by thyrotropin. 225
Molecular interactions at the cell surface: role of glycoconjugates and membrane lipids in receptor recognition processes. 222
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 222
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 221
V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER 220
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 219
Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. 217
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib 217
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 216
uptake of amiodarone by thyroidal and non-thyroidal cell lines 215
In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity 215
Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. 215
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 214
Results of Vardenafil Mediated Power Doppler Ultrasound, Contrast Enhanced Ultrasound and Systematic Random Biopsies to Detect Prostate Cancer 210
Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. 209
Thyrotropin stimulation of the ADP-ribosyltransferase activity of bovine thyroid membranes. 208
A study on the relationship between intraglandular arterial distribution and thyroid lobe shape: implications for biotechnology of a bioartificial thyroid 207
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 207
Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma 207
Thyroid-stimulating antibody mimics thyrotropin in its ability to desensitize the adenosine 3',5'-monophosphate response to acute stimulation in continuously cultured rat thyroid cells (FRT-L5). 205
Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. 204
STUDY OF POTENTIAL INHIBITORS OF THYROID IODIDE UPTAKE BY USING CHO CELLS STABLY EXPRESSING THE HUMAN SODIUM/IODIDE SYMPORTER (hNIS) PROTEIN 204
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 204
Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts 204
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 204
Effects of bariatric surgery on preclinical myocardial alterations in severe obesity 203
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 203
Causes and laboratory investigations of thyrotoxicosis 203
Thyroglobulin Antibodies (TgAb) Titer Spontaneously Decrease Until The Negativization Or Stabilization In Most Of Cases Of Papillary Thyroid Microcarcinoma (mPTC) Treated With Total Thyroidectomy But Not Ablated With 131I 203
Diagnosis of thyroid dysfunction: present and future. 202
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. 201
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 201
Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women 200
Interference of serum thyroglobulin in the radioassay for serum antithyroglobulin antibodies. 199
mRECIST criteria to assess recurrent thyroid carcinoma treatment response after radiofrequency ablation: a prospective study 199
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre 199
Graves' Disease Induced by Immune Checkpoint Inhibitors: A case report and Review of the literature 199
Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay. 198
Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules 198
[Thyroid-stimulating immunoglobulins. The related antigens] 197
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center 197
Effect of thyroglobulin autoantibodies on the metabolic clearance of serum thyroglobulin 197
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 196
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 196
DIAGNOSTIC AND THERAPEUTIC ROLE OF THYROID REMNANT ABLATION WITH LOW ACTIVITY OF 131I IN PATIENTS WITH LOW AND INTERMEDIATE RISK PAPILLARY THYROID CARCINOMA (PTC). 195
Electric and magnetic fields do not modify the biochemical properties of FRTL-5 cells 193
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 193
Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma 193
Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: Insights fromthe EYESHOT study 193
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 192
Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. 191
The expression of platelet serotonin transporter (SERT) in human obesity 191
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 191
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 191
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease 190
Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter 189
Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato 189
Thyroglobulin Autoantibodies arise before Thyroperoxidase Autoantibodies in Juvenile Autoimmune Thyroiditis 189
Agretti P, De Marco G, De Servi M, Marcocci C, Vitti P, Pinchera A, Tonacchera M.: Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation 188
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 188
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO) 188
ROLE OF THYROID REMNANT ABLATION WITH LOW ACTIVITY OF 131I IN PATIENTS WITH LOW AND INTERMEDIATE RISK PAPILLARY THYROID CARCINOMA (PTC). 187
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 187
TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells 187
Percutaneous ethanol injection: what is its role in the management of nodular lesions of endocrine glands? 186
Prevalence of thyroid peroxidase, thyroglobulin and thyrotropin receptor antibodies in a long-term follow-up of juvenile Graves disease 186
Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease. 186
Totale 34.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.716 0 234 135 381 1.188 831 173 268 464 364 239 1.439
2022/20237.857 848 940 574 644 813 909 173 604 1.313 168 637 234
2023/20249.104 736 621 683 438 802 1.003 374 539 246 2.615 394 653
2024/202516.049 293 714 399 1.106 1.491 1.462 1.241 978 1.669 2.133 1.616 2.947
2025/202618.313 1.224 2.027 1.877 1.517 1.650 1.376 2.617 790 2.775 1.426 638 396
2026/20271.761 819 942 0 0 0 0 0 0 0 0 0 0
Totale 86.422